{"id":89214,"date":"2023-11-27T09:06:15","date_gmt":"2023-11-27T14:06:15","guid":{"rendered":"https:\/\/ifintechworld.com\/uncategorized\/barclays-updates-ftse-stock-targets-astrazeneca-and-admiral-rise\/"},"modified":"2023-11-27T09:06:17","modified_gmt":"2023-11-27T14:06:17","slug":"barclays-updates-ftse-stock-targets-astrazeneca-and-admiral-rise","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=89214","title":{"rendered":"Barclays updates FTSE stock targets, AstraZeneca and Admiral rise"},"content":{"rendered":"
\n
\n

\u00a9 Reuters. <\/span>
\n<\/i>\n<\/div>\n

LONDON – Barclays has made a series of recalibrations to its price targets on a range of FTSE-listed stocks, reflecting a mix of optimism and caution in its latest assessments. Beazley PLC saw its price target trimmed but retained an ‘Overweight’ rating at \u00a38.00. Aviva <\/span><\/span> (LON:) PLC enjoyed a modest increase to \u00a34.80, while Admiral Group <\/span><\/span> (LON:) PLC’s target was ambitiously raised to \u00a330.44.<\/p>\n

In a contrasting move, Spirax-Sarco Engineering PLC faced a significant cut in its price target to \u00a398.70 but maintained an ‘Equal weight’ status. AstraZeneca PLC (LON:) also experienced a reduction in its target, now set at \u00a3125.00, yet the pharmaceutical giant continued to hold a ‘Buy’ rating.<\/p>\n

This reshuffling of valuations follows a week of varied adjustments across the financial sector. On Friday, Burberry Group (OTC:) PLC’s price target was dialed back by Deutsche Bank to \u00a319.50, reflecting a more conservative outlook.<\/p>\n

In the mid-cap sector, Virgin Money (LON:) UK PLC navigated through downgraded forecasts from Citigroup and RBC, with their targets settling between \u00a31.82 and \u00a32.10, respectively. Direct Line Insurance Group PLC and Just Group PLC found favor in Barclays’ eyes, as their targets were lifted, enhancing their market positions.<\/p>\n

Even smaller-cap entities like Sabre (NASDAQ:) Insurance Group PLC and Old Mutual Limited weren’t left out of the adjustments, both receiving slight increases in their Barclays-set valuations.<\/p>\n

The recalibrations come amid a broader context of market reevaluations by financial institutions. Peel Hunt and Numis both upgraded Rightmove (OTC:) PLC with a ‘Buy’ rating and a specific target of \u00a36.75 by Numis. Conversely, Goldman Sachs took a bearish turn on Entain PLC, slashing its price target from \u00a314.50 to \u00a38.20 and downgrading the stock from ‘Buy’ to ‘Sell’.<\/p>\n

In the energy sector, RBC Capital Markets has raised its sights on BP (NYSE:) PLC, setting an elevated target of \u00a36.25 (GBP1 = USD1.2619) due to anticipated outperformance.<\/p>\n

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.<\/em><\/p>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

\u00a9 Reuters. LONDON – Barclays has made a series of recalibrations to its price targets on a range of FTSE-listed stocks, reflecting a mix of optimism and caution in its latest assessments. Beazley PLC saw its price target trimmed but retained an ‘Overweight’ rating at \u00a38.00. Aviva (LON:) PLC enjoyed a modest increase to \u00a34.80, […]<\/p>\n","protected":false},"author":1,"featured_media":2931,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[1],"tags":[83],"class_list":["post-89214","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-uncategorized","tag-featured","post_format-post-format-video"],"yoast_head":"\nBarclays updates FTSE stock targets, AstraZeneca and Admiral rise | iFintechWorld<\/title>\n<meta name=\"description\" content=\"\u00a9 Reuters. LONDON - Barclays has made a series of recalibrations to its price targets on a range of FTSE-listed stocks, reflecting a mix of optimism and\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=89214\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Barclays updates FTSE stock targets, AstraZeneca and Admiral rise | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"\u00a9 Reuters. LONDON - Barclays has made a series of recalibrations to its price targets on a range of FTSE-listed stocks, reflecting a mix of optimism and\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=89214\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-27T14:06:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-27T14:06:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/05\/LYNXNPEB6R0AQ_L.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"537\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=89214#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=89214\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"Barclays updates FTSE stock targets, AstraZeneca and Admiral rise\",\"datePublished\":\"2023-11-27T14:06:15+00:00\",\"dateModified\":\"2023-11-27T14:06:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=89214\"},\"wordCount\":337,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=89214#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=89214\",\"url\":\"https:\/\/ifintechworld.com\/?p=89214\",\"name\":\"Barclays updates FTSE stock targets, AstraZeneca and Admiral rise | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-11-27T14:06:15+00:00\",\"dateModified\":\"2023-11-27T14:06:17+00:00\",\"description\":\"\u00a9 Reuters. LONDON - Barclays has made a series of recalibrations to its price targets on a range of FTSE-listed stocks, reflecting a mix of optimism and\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=89214#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=89214\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=89214#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Barclays updates FTSE stock targets, AstraZeneca and Admiral rise\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Barclays updates FTSE stock targets, AstraZeneca and Admiral rise | iFintechWorld","description":"\u00a9 Reuters. LONDON - Barclays has made a series of recalibrations to its price targets on a range of FTSE-listed stocks, reflecting a mix of optimism and","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=89214","og_locale":"en_US","og_type":"article","og_title":"Barclays updates FTSE stock targets, AstraZeneca and Admiral rise | iFintechWorld","og_description":"\u00a9 Reuters. LONDON - Barclays has made a series of recalibrations to its price targets on a range of FTSE-listed stocks, reflecting a mix of optimism and","og_url":"https:\/\/ifintechworld.com\/?p=89214","og_site_name":"iFintechWorld","article_published_time":"2023-11-27T14:06:15+00:00","article_modified_time":"2023-11-27T14:06:17+00:00","og_image":[{"width":800,"height":537,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/05\/LYNXNPEB6R0AQ_L.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=89214#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=89214"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"Barclays updates FTSE stock targets, AstraZeneca and Admiral rise","datePublished":"2023-11-27T14:06:15+00:00","dateModified":"2023-11-27T14:06:17+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=89214"},"wordCount":337,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=89214#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=89214","url":"https:\/\/ifintechworld.com\/?p=89214","name":"Barclays updates FTSE stock targets, AstraZeneca and Admiral rise | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-11-27T14:06:15+00:00","dateModified":"2023-11-27T14:06:17+00:00","description":"\u00a9 Reuters. LONDON - Barclays has made a series of recalibrations to its price targets on a range of FTSE-listed stocks, reflecting a mix of optimism and","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=89214#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=89214"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=89214#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"Barclays updates FTSE stock targets, AstraZeneca and Admiral rise"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/89214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=89214"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/89214\/revisions"}],"predecessor-version":[{"id":89215,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/89214\/revisions\/89215"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/2931"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=89214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=89214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=89214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}